JPRN-UMIN000010880
Completed
未知
Effect of Linagliptin on daily glucose excursion in Continuous Glucose Monitoring of Type2 diabetic patients - L-CGM
Japan society of Patient Reported Outcome0 sites100 target enrollmentJune 5, 2013
ConditionsType 2 Diabetes
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Type 2 Diabetes
- Sponsor
- Japan society of Patient Reported Outcome
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Type 1 and secondary diabetes 2\.Severe infectious disease, before or after surgery, and severe trauma 3\.Events of myocardial infarction, cerebral stroke, cerebral infarction and TIA in the past 3 month. 4\.Moderate or severer heart failure(NYHA/New York Heart Association stage III or severer) 5\.Severe liver dysfunction (ALT,AST and ALP face 3 times the normal level) 6\.Past medical history of hypersensitivity to investigational drugs. 7\.Patients addicted to alcohol and drugs. 8\.Pregnant, lactating, and possibly pregnant women and those planning to become pregnant. 9\.Patients with cancer. 10\.Patent receiving steroid therapy with inflammatory affection. 11\.Past medical history of abdominal operation and ileus. 12\.Judged as ineligible by clinical investigators.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Efficacy of linagliptin on glycemic control in diabetic patients on hemodialysis [Diamond study-1]Diabetic patients on hemodialysisJPRN-UMIN000007635Diamond study group80
Completed
Not Applicable
Effects of sitagliptin on daily glucose fluctuation in Japanese type 2 diabetic outpatients inadequately controlled with insulin therapyJPRN-UMIN000012735Aichi Medical University Division of Diabetes, Department of Internal Medicine, Diabetes Center30
Completed
Not Applicable
Study of the effect of anagliptin on glucose and lipid metabolism abnormality after the test meal loading.JPRN-UMIN000011424Kanazawa Medical University10
Not yet recruiting
Phase 3
Efficiency of linagliptin on insulin dosage in type 2 diabetes patientsType 2 diabetes.Type 2 diabetes mellitusIRCT20210609051526N1Babol University of Medical Sciences96
Not yet recruiting
Not Applicable
The effect of omarigliptin on glucose excursion using continuous glucose monitoring in the elderly patients with type2 diabetestype 2 diabetesJPRN-UMIN000021815Department of Endoclinology, Gifu University Graduate School of Medicine10